34º Congresso Mineiro de Cardiologia
Acesse o site do congresso
1º Dia - 7/10/25
2º Dia - 7/11/25
3º Dia - 7/12/25

Aula SC 6D: O uso do DOAC nas doenças valvares Voltar

Willian Antônio Esteves

Sessão científica 6: Simpósio de Atualização em Valvopatias - Braulio Muzzi e Márcia Barbosa

Artigo Autor(es) Referência
Comparison of the Direct Oral Anticoagulants and Warfarin in Patients With Atrial Fibrillation and Valvular Heart Disease: Updated Systematic Review and Meta-Analysis of Randomized Controlled Trials. Bitar Yasmin de Souza Lima, Duraes Andre Rodrigues, Roever Leonardo, Gomes Neto Mansueto, Lins-Kusterer Liliane, Bocchi Edimar Alcides Frontiers in cardiovascular medicine. 2021 ; 8():712585. doi: 10.3389/fcvm.2021.712585. pii: .
DOACs in Mechanical and Bioprosthetic Heart Valves: A Narrative Review of Emerging Data and Future Directions. Ryu Rachel, Tran Rebecca Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis. 28():10760296221103578. doi: 10.1177/10760296221103578. pii: .
DOACs in the Anticoagulation of Mechanical Valves: A Systematic Review and Future Perspectives. Langenaeken Tom, Vanoppen Arnaud, Janssens Fien, Tanghe Loes, Verbrugghe Peter, Rega Filip, Meuris Bart Journal of clinical medicine. 2023 Jul; 12(Jul):doi: 10.3390/jcm12154984. pii: 4984.
Direct Acting Oral Anticoagulant vs. Warfarin in the Prevention of Thromboembolism in Patients With Non-valvular Atrial Fibrillation With Valvular Heart Disease-A Systematic Review and Meta-Analysis. Martha Januar Wibawa, Pranata Raymond, Raffaelo Wilson Matthew, Wibowo Arief, Akbar Mohammad Rizki Frontiers in cardiovascular medicine. 2021 ; 8():764356. doi: 10.3389/fcvm.2021.764356. pii: .
Direct Oral Anticoagulants in Patients With Atrial Fibrillation and Valvular Heart Disease Other Than Significant Mitral Stenosis and Mechanical Valves: A Meta-Analysis. Siontis Konstantinos C, Yao Xiaoxi, Gersh Bernard J, Noseworthy Peter A Circulation. 2017 02; 135(02):714-716. doi: 10.1161/CIRCULATIONAHA.116.026793. pii: .
Direct oral anticoagulant use in nonvalvular atrial fibrillation with valvular heart disease: a systematic review. Owens Ryan E, Kabra Rajesh, Oliphant Carrie S Clinical cardiology. 2017 Jun; 40(Jun):407-412. doi: 10.1002/clc.22659. pii: .
Evaluation of the Safety and Effectiveness of Direct-Acting Oral Anticoagulants in Patients with Atrial Fibrillation and Coexisting Valvular Heart Disease. Hampton Meredith L, Tellor Katie B, Armbruster Anastasia L, Theodos Gus, Schwarze Martin W American journal of cardiovascular drugs : drugs, devices, and other interventions. 2020 Dec; 20(Dec):611-617. doi: 10.1007/s40256-020-00398-x. pii: .
Optimizing Anticoagulation Strategies in Patients With Atrial Fibrillation and Valvular Heart Disease: A Comprehensive Evidence-Based Review. Deiveegan Dharani S, Salahie Mohamed, Subhan Muhammad, Ismail Sulman, Khan Muhammad Abdullah, Raval Darshankumar M, Abbas Usama, Betsy Baiju Beyla, Abuasaker Husam K, Bibi Ruqiya Cureus. 2025 Mar; 17(Mar):e81319. doi: 10.7759/cureus.81319. pii: e81319.
Oral anticoagulation for stroke prevention amongst atrial fibrillation patients with valvular heart disease: an update. Ha Andrew C T, Verma Atul, Verma Subodh Current opinion in cardiology. 2017 Mar; 32(Mar):174-180. doi: 10.1097/HCO.0000000000000365. pii: .
Outcomes of Direct Oral Anticoagulants in Patients with Atrial Fibrillation and Valvular Heart Disease. Dawwas Ghadeer K, Barnes Geoffrey D Current cardiology reports. 2022 Jun; 24(Jun):731-738. doi: 10.1007/s11886-022-01690-9. pii: .
Nenhuma revista foi definida para este congresso.